Could amniotic fluid help women regrow thinning hair?

NCT ID NCT07221773

ENROLLING_BY_INVITATION Disease control Sponsor: Restore Biologics Holdings, Inc. dba Xtressé Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether a solution made from human amniotic fluid, called XVIE, can safely improve hair growth in women who feel their hair is thinning. Fifteen women will receive two treatments over four months, applied to the scalp via microneedling. Researchers will track changes in hair volume and thickness using photos and check for side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: XVIE (human amniotic fluid derived nanoparticle solution)
What this could lead to: If it works, this could point toward a new treatment for hair thinning in women.
What could go wrong: This is a very small pilot study with only 15 women, so results may not apply to everyone. It's early-stage and not yet proven effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAIR THINNING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HAIR THINNING

Contacts and locations

Locations

Advanced Dermatology & Cosmetic Surgery

Maitland, Florida, 32751, United States
Kindred Hair & Skin Center

Marriottsville, Maryland, 21104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.